Sign In

Login

Password

Forgot Password ? Sign Up

Covaxin (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Covaxin" in Japanese language version.

refsWebsite
Global rank Japanese rank
5nih.gov
4th place
24th place
4indianexpress.com
60th place
2,503rd place
4thehindu.com
52nd place
2,179th place
4doi.org
2nd place
6th place
3livemint.com
390th place
7,256th place
2theprint.in
987th place
8,932nd place
2nytimes.com
7th place
63rd place
2hindustantimes.com
71st place
2,422nd place
1ddnews.gov.in
low place
low place
1washingtonpost.com
34th place
255th place
1thelancet.com
2,393rd place
4,709th place
1clinicaltrials.gov
5,225th place
low place
1wikipedia.org
low place
low place
1ndtv.com
138th place
2,970th place
1business-standard.com
350th place
6,106th place
1businesstoday.in
1,332nd place
low place
1newindianexpress.com
188th place
8,352nd place
1reuters.com
49th place
67th place
1indiatimes.com
17th place
799th place
1bbc.com
20th place
100th place
1thewire.in
1,507th place
low place
1firstpost.com
283rd place
3,870th place

bbc.com

business-standard.com

businesstoday.in

clinicaltrials.gov

ddnews.gov.in

doi.org

firstpost.com

hindustantimes.com

indianexpress.com

indiatimes.com

economictimes.indiatimes.com

livemint.com

ndtv.com

newindianexpress.com

nih.gov

pmc.ncbi.nlm.nih.gov

  • Ella, Raches; Vadrevu, Krishna Mohan; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi; Ganneru, Brunda; Sapkal, Gajanan et al. (21 January 2021). “Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial” (English). The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30942-7. PMC 7825810. PMID 33485468. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30942-7/fulltext. 
  • Hoeksema F, Karpilow J, Luitjens A, Lagerwerf F, Havenga M, Groothuizen M, Gillissen G, Lemckert AA, Jiang B, Tripp RA, Yallop C (April 2018). “Enhancing viral vaccine production using engineered knockout vero cell lines - A second look”. Vaccine 36 (16): 2093–2103. doi:10.1016/j.vaccine.2018.03.010. PMC 5890396. PMID 29555218. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890396/. 

pubmed.ncbi.nlm.nih.gov

  • Ella, Raches; Vadrevu, Krishna Mohan; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi; Ganneru, Brunda; Sapkal, Gajanan et al. (21 January 2021). “Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial” (English). The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30942-7. PMC 7825810. PMID 33485468. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30942-7/fulltext. 
  • Hoeksema F, Karpilow J, Luitjens A, Lagerwerf F, Havenga M, Groothuizen M, Gillissen G, Lemckert AA, Jiang B, Tripp RA, Yallop C (April 2018). “Enhancing viral vaccine production using engineered knockout vero cell lines - A second look”. Vaccine 36 (16): 2093–2103. doi:10.1016/j.vaccine.2018.03.010. PMC 5890396. PMID 29555218. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890396/. 

ncbi.nlm.nih.gov

nytimes.com

reuters.com

thehindu.com

thelancet.com

  • Ella, Raches; Vadrevu, Krishna Mohan; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi; Ganneru, Brunda; Sapkal, Gajanan et al. (21 January 2021). “Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial” (English). The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30942-7. PMC 7825810. PMID 33485468. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30942-7/fulltext. 

theprint.in

thewire.in

science.thewire.in

washingtonpost.com

wikipedia.org

en.wikipedia.org